SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000875320-17-000014
Filing Date
2017-02-13
Accepted
2017-02-13 09:07:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G schedule13g.htm SC 13G 60270
  Complete submission text file 0000875320-17-000014.txt   61769
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filed by) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89674 | Film No.: 17596173
SIC: 2836 Biological Products, (No Diagnostic Substances)